Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Stussi

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Bone Marrow Transplantation|March 1, 2023
BleedHD-a new electronic assessment tool for grading chronic graft-versus-host disease validated in a multicenter and multiprofessional settingAndrea Warthmann, Andreas Holbro, Andreas Buser, et al.
Haematologica|January 16, 2009
Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutininsGeorg Stussi, Jörg Halter, Eveline Bucheli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphismsFlorence Bettens, Jakob Passweg, Urs Schanz, et al.
Leukemia & Lymphoma|April 4, 2013
Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07)Jakob R Passweg, Thomas Pabst, Sabine Blum, et al.
Annals of Hematology|July 17, 2024
Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expressionMax J Rieger, Thomas Pabst, Barbara Jeker, et al.
Cancer Epidemiology|January 29, 2019
Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registriesSonia Benzarti, Michael Daskalakis, Anita Feller, et al.
Transplantation|January 25, 2008
Flow cytometric measurement of ABO antibodies in ABO-incompatible living donor kidney transplantationGisella Puga Yung, Piero V Valli, Astrid Starke, et al.
British Journal of Haematology|July 2, 2013
Prognostic impact of monocyte count at presentation in mantle cell lymphomaKathrin Aprile von Hohenstaufen, Annarita Conconi, Cassio Polpo de Campos, et al.
Blood|August 1, 2007
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantationAndré Tichelli, Christoph Bucher, Alicia Rovó, et al.
Swiss Medical Weekly|April 6, 2023
Acquired haemophilia A in southern Switzerland from 2013 to 2019: a case seriesAndrea Ruberti, Johanna A Kremer Hovinga, Federico Nappi, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Bone Marrow Transplantation|March 1, 2023
BleedHD-a new electronic assessment tool for grading chronic graft-versus-host disease validated in a multicenter and multiprofessional settingAndrea Warthmann, Andreas Holbro, Andreas Buser, et al.
Haematologica|January 16, 2009
Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutininsGeorg Stussi, Jörg Halter, Eveline Bucheli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphismsFlorence Bettens, Jakob Passweg, Urs Schanz, et al.
Leukemia & Lymphoma|April 4, 2013
Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07)Jakob R Passweg, Thomas Pabst, Sabine Blum, et al.
Annals of Hematology|July 17, 2024
Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expressionMax J Rieger, Thomas Pabst, Barbara Jeker, et al.
Cancer Epidemiology|January 29, 2019
Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registriesSonia Benzarti, Michael Daskalakis, Anita Feller, et al.
Transplantation|January 25, 2008
Flow cytometric measurement of ABO antibodies in ABO-incompatible living donor kidney transplantationGisella Puga Yung, Piero V Valli, Astrid Starke, et al.
British Journal of Haematology|July 2, 2013
Prognostic impact of monocyte count at presentation in mantle cell lymphomaKathrin Aprile von Hohenstaufen, Annarita Conconi, Cassio Polpo de Campos, et al.
Blood|August 1, 2007
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantationAndré Tichelli, Christoph Bucher, Alicia Rovó, et al.
Swiss Medical Weekly|April 6, 2023
Acquired haemophilia A in southern Switzerland from 2013 to 2019: a case seriesAndrea Ruberti, Johanna A Kremer Hovinga, Federico Nappi, et al.
Pageof 9